Dr. Fitz-Patrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1585 Kapiolani Blvd
Suite 1500
Honolulu, HI 96814Phone+1 808-531-6886Fax+1 808-523-5115
Education & Training
- University of MarylandResidency, Internal Medicine, 1975 - 1977
- University of Newcastle Upon Tyne Faculty of MedicineClass of 1974
Certifications & Licensure
- HI State Medical License 1981 - 2026
- MD State Medical License 1976 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
- A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial.David Fitz-Patrick, Hanako Mihara, Anthony Mills, Runa Mithani, Archana Kapoor
Respiratory Investigation. 2024-11-01 - Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Dia...Elena A Christofides, Andrzej Stankiewicz, Douglas Denham, Diego Bellido, Edward Franek
Endocrine Practice. 2024-09-01 - Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 di...Elena A Christofides, Orlando Puente, Paul Norwood, Douglas Denham, Hiralal Maheshwari
Diabetes, Obesity & Metabolism. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: